Bootsma H, Spronk P E, Hummel E J, de Boer G, ter Borg E J, Limburg P C, Kallenberg C G
Department of Internal Medicine, University Hospital Groningen, The Netherlands.
Scand J Rheumatol. 1996;25(6):352-9. doi: 10.3109/03009749609065646.
We determined the discriminative value of the Farr assay in comparison to ELISA and Crithidia luciliae immunofluorescence assay (IFT) for detecting anti-dsDNA antibodies as a diagnostic tool for systemic lupus erythematosus (SLE). Special attention was paid to the diagnostic significance of IgM-class anti-dsDNA. Sera were analyzed from 74 patients with SLE, 257 patients with other auto-immune diseases, and 50 healthy controls. All sera were tested for anti-dsDNA using the IFT (anti-total immunoglobulin conjugate), ELISA (anti-IgG and anti-IgM conjugates), and the 125I Farr assay. Specificity and sensitivity for a diagnosis of SLE appeared to be highest for the Farr. All SLE sera with IgM-class anti-dsDNA without IgG-class anti-dsDNA as detected by ELISA, were positive when tested by the Farr assay. In contrast, most of the sera with IgM-class anti-dsDNA as detected by ELISA from patients with diseases other than SLE were negative when tested by Farr assay.
我们确定了Farr试验相对于酶联免疫吸附测定(ELISA)和利什曼原虫免疫荧光试验(IFT)在检测抗双链DNA(dsDNA)抗体作为系统性红斑狼疮(SLE)诊断工具方面的鉴别价值。特别关注了IgM类抗dsDNA的诊断意义。分析了74例SLE患者、257例其他自身免疫性疾病患者和50例健康对照者的血清。所有血清均使用IFT(抗总免疫球蛋白结合物)、ELISA(抗IgG和抗IgM结合物)和125I Farr试验检测抗dsDNA。Farr试验对SLE诊断的特异性和敏感性似乎最高。ELISA检测到的所有无IgG类抗dsDNA的IgM类抗dsDNA的SLE血清,经Farr试验检测均为阳性。相比之下,ELISA检测到的大多数非SLE疾病患者的IgM类抗dsDNA血清,经Farr试验检测为阴性。